EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells

Catherine A Lewis iD, David M Margolis, Edward P Browne iD

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1013073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Catherine A Lewis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States…. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, HIV-1, vpr Gene Products, Human Immunodeficiency Virus, Virus Latency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiretroviral therapy (ART) has dramatically improved the clinical prognosis for people with HIV and prevents HIV transmission. However, ART does not cure HIV infection because of a persistent, latent viral reservoir in long-lived cells such as central memory CD4 + T (T CM ) cells. Eliminating or preventing reservoir formation will require a better understanding of HIV-1 latency establishment. We and others have recently shown that host cell factors such as histone deacetylases (HDACs) are critical cellular factors that allow HIV-1 entry into latency. Whether HDACs interact with specific viral factors to regulate latency establishment, however, is unknown. To examine the role of individual HIV-1 accessory proteins, we constructed a panel of HIV-1 reporter strains, each expressing a single HIV-1 accessory protein, and examined them in a primary CD4 + T-cell latency model. Interestingly, we found that the HDAC inhibitor (HDACi) vorinostat potently enhances the effect of the HIV-1 protein Vpr in promoting HIV expression in infected cells, suggesting that Vpr possesses a cryptic transcription-promoting activity that is restricted by HDACs. This activity was dependent on a p300-binding domain of Vpr and inhibited by a selective p300 histone acetyltransferase inhibitor. Interestingly, Vpr expression also resulted in a significant increase in the proportion of infected cells with a central memory (T CM ) phenotype. Furthermore, we observed that T CM cells were more resistant to Vpr-induced apoptosis/cell death than other CD4 + T-cell subtypes, indicating that Vpr expression during reservoir formation selects for latent proviruses in T CM cells. Overall, these findings suggest that Vpr plays an important role in shaping the latent reservoir and that HIV-1 latency results, in part, from an HDAC-mediated restriction of Vpr’s transcription-promoting activity. Understanding how viral factors shape the latent reservoir and how host and viral factors interact during HIV-1 latency establishment in CD4 + T cells will aid in the development of new latency-targeting therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD4-Positive T-LymphocytesHIV-1vpr Gene Products, Human Immunodeficiency VirusVirus LatencyHIV InfectionsHistone DeacetylasesE1A-Associated p300 ProteinHumansHistone Deacetylase InhibitorsTranscription, GeneticVorinostatHydroxamic Acids

Substanzen

vpr Gene Products, Human Immunodeficiency VirusHistone Deacetylase InhibitorsHistone Deacetylasesvpr protein, Human immunodeficiency virus 1E1A-Associated p300 ProteinEP300 protein, humanVorinostatHydroxamic Acids

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America.
  • University of North Carolina HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America.
  • Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America.

ORCID-Profile: Catherine A Lewis, Edward P Browne

Förderung

  • NIAID NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Lewis, C. A., Margolis, D. M., & Browne, E. P. (2025). HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013073

Vancouver

Lewis CA, Margolis DM, Browne EP. HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013073

BibTeX
@article{Lewis2025,
  author = {Lewis, Catherine A and Margolis, David M and Browne, Edward P},
  title = {HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1013073}
}
Kostenlos starten →